Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Novo Nordisk to discontinue Levemir insulin by end of 2026
Novo Nordisk has announced that it will stop producing Levemir insulin by the end of 2026. If you currently use Levemir, this news may be concerning, but there are plans in place to help you transition smoothly to an alternative.
The Department of Health and Social Care (DHSC), NHS England, and clinical experts are working together to provide guidance and support. A Medicines Supply Notification will be issued to help prescribers understand what alternative options are available.
We understand that changes to medication can be unsettling, but there is time to discuss your options. The withdrawal date at the end of 2026 gives you and your healthcare professional the opportunity to find the best alternative for you.
You don’t need to book an appointment yourself. Your healthcare team will contact you to arrange one and decide which new insulin is best for you, based on your current treatment. They’ll make sure you’re trained on any new device, understand your dose, and feel confident managing your blood glucose. If you have any questions, please raise them with your healthcare team during your appointment.
Find out about the global research we're funding to find cures and better treatments for T1D.
Get information and advice about living well with type 1.
Join our mission to find cures for T1D and, until then, make life better for people living with it.
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
We’re aware of growing concern around insulin supply in the UK, and we want to reassure our community that this is not a general insulin shortage. There is no need to change the type of insulin you use.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
